Data / Form D filings / MINERVA BIOTECHNOLOGIES Corp
MINERVA BIOTECHNOLOGIES Corp: Form D filings
MINERVA BIOTECHNOLOGIES Corp, a biotechnology company in Waltham, MA, filed 10 Form D notices with the SEC between 2010 and 2023. The latest, on December 5, 2023, reports $4.5 million sold of a $8 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 40 BEAR HILL ROAD, Waltham, MA, 02451
- Phone
- (781) 487-0200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1087376
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 5, 2023 | New notice | $8,000,000 | $4,515,000 | $3,485,000 | 9 | Nov 14, 2023 | sec.gov |
| Jan 4, 2023 | Amendment | $30,000,000 | $327,720 | $29,672,280 | 5 | Feb 14, 2022 | sec.gov |
| Feb 23, 2022 | New notice | $25,000,000 | $125,250 | $24,874,750 | 1 | Feb 14, 2022 | sec.gov |
| Jan 28, 2022 | Amendment | $30,000,000 | $24,073,157 | $5,926,843 | 65 | Oct 17, 2019 | sec.gov |
| Oct 30, 2019 | New notice | $12,000,000 | $1,545,008 | $10,454,992 | 7 | Oct 17, 2019 | sec.gov |
| Apr 5, 2019 | New notice | $12,000,000 | $4,231,000 | $7,769,000 | 9 | Mar 22, 2019 | sec.gov |
| Oct 2, 2018 | New notice | $31,200,000 | $29,342,194 | $1,857,806 | 79 | Oct 10, 2014 | sec.gov |
| Oct 24, 2014 | New notice | $30,000,000 | $2,000,000 | $28,000,000 | 1 | Oct 10, 2014 | sec.gov |
| Nov 17, 2010 | New notice | $5,900,000 | $4,634,580 | $1,265,420 | 17 | Nov 3, 2010 | sec.gov |
| Feb 23, 2010 | New notice | $5,000,000 | $1,605,632 | $3,394,368 | 20 | Jul 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth Kosik | Director | |
| James R. Bridges | Director | |
| Robert Staszewski | Director | |
| Ronald R. Axelrod | Director | |
| Joseph Anthony Nathan | Director | |
| Lawrence Anthony Coolidge | Director | |
| Kenneth Anthony Reed | Director | |
| Cynthia Bamdad | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 4, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MINERVA BIOTECHNOLOGIES Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.